FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Genentech | Avian Flu | biomarkers | Tanox | FTC

ALSO NOTED: Feds ask Genentech for more merger info; Japan confirms bird flu outbreak; and much more...

> The FTC has asked for more information about Genentech's proposed merger with Tanox. Report

> Japan has confirmed the third outbreak of avian flu in poultry. Report

> The head of ArQule's scientific advisory board will become the CEO of the newly-established Boston Biomedical. BBI will conduct scientific research under an eight-month contract with ArQule that will include a number of in vivo and in vitro studies, reports and publications related to mechanisms of action and biomarkers for ArQule's lead products, which are in human clinical trials. Release

> OncoGenex has priced its IPO of 4.5 million shares at $10 to $12 each. Report

> The FDA has approved Berlex's YAZ to treat moderate acne in women who want to use an oral contraceptive for birth control. Release

> Beijing Med-Pharm has acquired a stake in Guangzhou Pharmaceuticals, China's third-largest drug wholesaler. Release

And Finally… Researchers say that hard work and simple living have made one small town in Italy one of the healthiest places on the planet. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Genentech   Avian Flu   biomarkers   Tanox   FTC